These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7018166)

  • 41. Controlled study comparing vaginal prostaglandin E2 pessaries with intravenous oxytocin for the stimulation of labour after spontaneous rupture of the membranes.
    Magos AL; Noble MC; Wong Ten Yuen A; Rodeck CH
    Br J Obstet Gynaecol; 1983 Aug; 90(8):726-31. PubMed ID: 6576807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of labour: a comparison of a single prostaglandin E2 vaginal tablet with amniotomy and intravenous oxytocin.
    Kennedy JH; Stewart P; Barlow DH; Hillan E; Calder AA
    Br J Obstet Gynaecol; 1982 Sep; 89(9):704-7. PubMed ID: 7052115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.
    Rabl M; Joura EA; Yücel Y; Egarter C
    J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous infusion of prostaglandin E2 for management of premature rupture of membranes.
    Thiery M; Parewijck W; Martens G
    Z Geburtshilfe Perinatol; 1982; 186(2):87-8. PubMed ID: 7202303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Induction of labor by means of oral prostaglandin E2, buccal demoxytocin or automatic oxytocin infusion system].
    Lykkesfeldt G; Osler M
    Ugeskr Laeger; 1978 Apr; 140(16):909-13. PubMed ID: 349810
    [No Abstract]   [Full Text] [Related]  

  • 46. Misoprostol as a labor induction agent.
    Magtibay PM; Ramin KD; Harris DY; Ramsey PS; Ogburn PL
    J Matern Fetal Med; 1998; 7(1):15-8. PubMed ID: 9502664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial.
    Sanchez-Ramos L; Kaunitz AM; Del Valle GO; Delke I; Schroeder PA; Briones DK
    Obstet Gynecol; 1993 Mar; 81(3):332-6. PubMed ID: 8437780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Premature rupture of the fetal membranes--an active or expectant approach in management of this obstetrical problem].
    Milasinović L; Radeka G; Petrović D; Orelj M; Savin A
    Med Pregl; 1998; 51(7-8):346-9. PubMed ID: 9769670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extra-amniotic prostaglandin E2 gel vs. amniotomy for elective induction of labour.
    Thiery M; Parewijck W; Martens G; Derom R; van Kets H
    Z Geburtshilfe Perinatol; 1981 Dec; 185(6):323-6. PubMed ID: 7041450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracervical application of prostaglandin gel for induction of term labor.
    Ulmsten U; Wingerup L; Belfrage P; Ekman G; Wiqvist N
    Obstet Gynecol; 1982 Mar; 59(3):336-9. PubMed ID: 7043341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Premature rupture of fetal membranes at term: an indication for induced labor with prostaglandins?].
    Lettau R; Hege G; Steldinger R
    Zentralbl Gynakol; 1995; 117(3):121-5. PubMed ID: 7740844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second-trimester membrane rupture. Abortion induced with prostaglandin E2 after oxytocin failure.
    Atad J; Hallak M; Fruchter O; Borenstein J; Abramovici H
    J Reprod Med; 1997 Sep; 42(9):581-4. PubMed ID: 9336755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial of prostaglandin E2 gel and extra-amniotic saline infusion with high dose oxytocin for cervical ripening.
    Sharami SH; Milani F; Zahiri Z; Mansour-Ghanaei F
    Med Sci Monit; 2005 Aug; 11(8):CR381-6. PubMed ID: 16049380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes.
    Larrañaga-Azcárate C; Campo-Molina G; Pérez-Rodríguez AF; Ezcurdia-Gurpegui M
    Acta Obstet Gynecol Scand; 2008; 87(2):195-200. PubMed ID: 18231888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Misoprostol versus expectant management in premature rupture of membranes at term.
    da Graça Krupa F; Cecatti JG; de Castro Surita FG; Milanez HM; Parpinelli MA
    BJOG; 2005 Sep; 112(9):1284-90. PubMed ID: 16101609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin vaginal suppositories: a simple and safe approach to the induction of labor.
    Shepherd JH; Bennett MJ; Laurence D; Moore F; Sims CD
    Obstet Gynecol; 1981 Nov; 58(5):596-600. PubMed ID: 6946350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obstetric performance, perinatal outcome and risk of infection to the newborn in spontaneous and artificial rupture of membranes during labour.
    Seneviratne HR; de Silva GD; de Silva MV; Rudra T
    Ceylon Med J; 1998 Mar; 43(1):11-5. PubMed ID: 9624837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Induced and spontaneous labor: its duration and hourly frequency].
    Aighelboim I; Magnelli A; Zighelboim I
    Ginecol Obstet Mex; 1997 Nov; 65():470-3. PubMed ID: 9441148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of labour with single insertion of vaginal tablet of prostagladin E2 (PGE2), amniotomy, and oxytocin infusion.
    Odum CU; Isika AN; Lambo AO
    West Afr J Med; 1993; 12(3):153-7. PubMed ID: 8312212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaginal misoprostol in managing premature rupture of membranes.
    Ayad IA
    East Mediterr Health J; 2002; 8(4-5):515-20. PubMed ID: 15603033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.